A solid preparation useful as a diabetes-treating agent or the like and excellent in the dissolution properties of an insulin sensitizer and an insulin secretagogue, which comprises an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester is provided.

 
Web www.patentalert.com

< Integrated data collection and analysis for clinical study

< Integrated data collection and analysis for clinical study

> METHODS FOR NON-INVASIVE ANALYTE MEASUREMENT

> Tissue augmentation device

~ 00293